Baxter International Inc.
BAX Healthcare Medical Instruments & Supplies
Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024.
- Revenue
- +4.97%
- EPS
- +731.9%
- Free cash flow
- +255.6%
- Total debt
- −9.48%
Quarter to September 2026, against a year earlier
Follow BAX
Alert me
Baxter International Inc. (BAX) Book value per share
Baxter International Inc.'s book value per share at the end of fiscal 2025 was 11.9×, down 13.6% from 13.8× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 12.5×. Over the past ten years it has ranged from 11.7× (fiscal 2022) to 18.2× (fiscal 2021); the current reading is higher than 18% of that period. Baxter International Inc. ranks 22nd of 52 Medical Instruments & Supplies companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 11.9× | (13.63%) |
| FY2024 | 13.8× | (17.70%) |
| FY2023 | 16.7× | 43.08% |
| FY2022 | 11.7× | (35.63%) |
| FY2021 | 18.2× | 5.98% |
| FY2020 | 17.1× | 10.29% |
| FY2019 | 15.5× | 5.53% |
| FY2018 | 14.7× | (12.26%) |
| FY2017 | 16.8× | 10.71% |
| FY2016 | 15.2× | (6.77%) |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 12.5× | 4.79% |
| Jun 2026 | 12.0× | 2.31% |
| Mar 2026 | 11.7× | (1.79%) |
| Dec 2025 | 11.9× | (15.25%) |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| ALGN Align Technology, Inc. compare | 60.6× |
| COO The Cooper Companies, Inc. compare | 43.2× |
| WST West Pharmaceutical Services, Inc. compare | 42.2× |
| ATR AptarGroup, Inc. compare | 41.5× |
| RGEN Repligen Corporation compare | 37.0× |
| SOLV Solventum Corporation compare | 28.1× |
| BLCO Bausch + Lomb Corporation compare | 18.2× |
| BAX Baxter International Inc. | 12.5× |
| AVTR Avantor, Inc. compare | 8.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on BAX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement